Get the Stockscreener App
1.475
6.05%
-0.095
Perspective Therapeutics Inc Stock (CATX) Forecast
The Perspective Therapeutics Inc (CATX) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $2.2112, representing a +49.91% increase from the current price of $1.475. The highest analyst price target is $2.3979, and the lowest is $2.0244.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month CATX Price Target
Average 4.7353
(+221.04% Upside)
Is Perspective Therapeutics Inc (CATX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 41.86 | Neutral |
| STOCH(9,6) | 45.13 | Neutral |
| STOCHRSI(14) | 10.54 | Buy |
| MACD(12,26) | 0.0592 | Sell |
| ADX(14) | 30.82 | Sell |
| William %R | -70.94 | Neutral |
| CCI(14) | -197.92 | Sell |
Buy: 1
Sell: 3
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.735
Sell
|
1.6732
Sell
|
| MA20 |
1.685
Sell
|
1.6501
Sell
|
| MA50 |
1.4537
Buy
|
1.4549
Buy
|
| MA100 |
1.0825
Buy
|
1.1634
Buy
|
| MA200 |
0.644
Buy
|
0.00
Buy
|
Buy: 6
Sell: 4
Neutral: 0
Summary: Buy
According to our latest analysis, CATX could be considered a Neutral, with 17 technical analysis indicators signaling 7 Buy signals, 7 signaling Sell signals and 3 Neutral signals. This suggests that investors should exercise caution when entering new positions on CATX, as the market is likely to remain volatile in the near term.
- RSI (Relative Strength Index): The RSI(14) value of 41.86 indicates that CATX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 45.13 indicates that CATX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 10.54 indicates that CATX is oversold. This suggests that CATX price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 30.82 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -197.92 indicates that CATX is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term CATX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Perspective Therapeutics Inc financial reports and earnings history, Perspective Therapeutics Inc (CATX) stock could reach $28.25 by 2030, $75.48 by 2040 and $129.42 by 2050. See the projected annual prices until 2050 of the Perspective Therapeutics Inc stock below:
- Perspective Therapeutics Inc (CATX) is expected to reach an average price of $20.11 in 2035, with a high prediction of $81.50 and a low estimate of $20.11. This indicates an $1,263% rise from the last recorded price of $1.475.
- Perspective Therapeutics Inc (CATX) stock is projected to chart a bullish course in 2040, with an average price target of $75.37, representing an $5,010% surge from its current level. The forecast ranges from a conservative $67.97 to a sky-high $75.48.
- Our analysts predict Perspective Therapeutics Inc (CATX) to jump 2,624% by 2045, soaring from $37.20 to an average price of $40.17, potentially reaching $155.54. While $37.20 is the low estimate, the potential upside is significant.
- Perspective Therapeutics Inc (CATX) stock is expected to climb by 2050, reaching an average of $129.36, a $8,670% jump from its current level. However, a wide range of estimates exists, with high and low targets of $129.42 and $117.66, respectively, highlighting the market's uncertainty.
Perspective Therapeutics Inc Stock (CATX) Year by Year Forecast
Perspective Therapeutics Inc Stock (CATX) Price Forecast for 2024
Our forecast for CATX stock price in 2024 now indicates an average price target of $3.3485 with a high forecast of $6.3171 and a low forecast of $0.3799. The average prediction reflects an increase of +127.02% from the last recorded price of $1.475.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2024 | $2.3614 | $2.0244 | $2.3979 | +60.10% |
| July, 2024 | $2.9179 | $2.464 | $2.9377 | +97.82% |
| August, 2024 | $3.3801 | $3.025 | $3.3925 | +129.16% |
| September, 2024 | $4.1368 | $3.4769 | $4.2418 | +180.46% |
| October, 2024 | $5.0235 | $4.054 | $5.1234 | +240.58% |
| November, 2024 | $5.5216 | $4.9536 | $5.5216 | +274.34% |
| December, 2024 | $6.2121 | $5.6283 | $6.3171 | +321.16% |
Perspective Therapeutics Inc Stock (CATX) Price Forecast for 2025
Perspective Therapeutics Inc Stock (CATX) is expected to reach an average price of $8.0762 in 2025, with a high prediction of $13.14 and a low estimate of $3.0102. This indicates an +447.54% rise from the last recorded price of $1.475.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $7.2638 | $6.2844 | $7.2938 | +392.46% |
| February, 2025 | $3.378 | $3.0102 | $7.4461 | +129.02% |
| March, 2025 | $4.2747 | $3.5742 | $4.3062 | +189.81% |
| April, 2025 | $5.3617 | $4.4613 | $5.3765 | +263.51% |
| May, 2025 | $6.2502 | $5.5732 | $6.2774 | +323.74% |
| June, 2025 | $7.5189 | $6.4529 | $7.5489 | +409.75% |
| July, 2025 | $8.8722 | $7.6686 | $8.8722 | +501.51% |
| August, 2025 | $9.821 | $9.0178 | $9.8923 | +565.83% |
| September, 2025 | $11.09 | $10.03 | $11.18 | +651.83% |
| October, 2025 | $12.52 | $11.21 | $12.71 | +749.01% |
| November, 2025 | $4.4873 | $4.3253 | $13.14 | +204.22% |
| December, 2025 | $6.2638 | $4.8856 | $6.2953 | +324.66% |
Perspective Therapeutics Inc Stock (CATX) Price Forecast for 2026
The predicted value for Perspective Therapeutics Inc (CATX) in 2026 is set at an average of $12.24. Estimates vary from a peak of $18.84 to a trough of $5.6404, indicating an +729.79% surge from the present price of $1.475.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $7.5503 | $6.5627 | $7.6253 | +411.89% |
| February, 2026 | $8.9233 | $7.8724 | $8.9233 | +504.97% |
| March, 2026 | $10.41 | $9.2503 | $10.54 | +605.99% |
| April, 2026 | $12.51 | $10.73 | $12.55 | +747.88% |
| May, 2026 | $14.00 | $12.76 | $14.00 | +849.45% |
| June, 2026 | $15.46 | $14.23 | $15.62 | +948.29% |
| July, 2026 | $17.58 | $15.69 | $17.63 | +1,092% |
| August, 2026 | $5.6453 | $5.6404 | $18.84 | +282.73% |
| September, 2026 | $7.7759 | $5.9147 | $7.8571 | +427.18% |
| October, 2026 | $9.5778 | $8.2264 | $9.5944 | +549.34% |
| November, 2026 | $11.36 | $9.9748 | $11.37 | +669.95% |
| December, 2026 | $13.75 | $11.80 | $13.87 | +832.23% |
Perspective Therapeutics Inc Stock (CATX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Perspective Therapeutics Inc (CATX) is $15.79, with a high forecast of $24.62 and a low forecast of $6.9555. This indicates an +970.20% increase from the last price of $1.475.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $15.77 | $14.18 | $15.83 | +969.23% |
| February, 2027 | $17.82 | $16.23 | $17.89 | +1,108% |
| March, 2027 | $20.26 | $18.24 | $20.42 | +1,274% |
| April, 2027 | $22.46 | $20.60 | $22.58 | +1,423% |
| May, 2027 | $23.65 | $22.77 | $24.53 | +1,503% |
| June, 2027 | $9.1198 | $6.9555 | $9.1422 | +518.29% |
| July, 2027 | $11.33 | $9.6444 | $11.35 | +667.99% |
| August, 2027 | $13.57 | $11.88 | $13.59 | +820.02% |
| September, 2027 | $16.50 | $14.13 | $16.51 | +1,019% |
| October, 2027 | $18.85 | $17.07 | $18.96 | +1,178% |
| November, 2027 | $21.52 | $19.38 | $21.62 | +1,359% |
| December, 2027 | $24.62 | $21.90 | $24.62 | +1,569% |
Perspective Therapeutics Inc Stock (CATX) Price Forecast for 2028
In 2028, Perspective Therapeutics Inc (CATX) is projected to reach an average price of $22.10, with a high projection of $35.93 and a low estimate of $8.2706. This indicates an +1,398% rise from the last price of $1.475.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $27.15 | $24.99 | $27.27 | +1,741% |
| February, 2028 | $29.60 | $27.52 | $29.63 | +1,907% |
| March, 2028 | $10.19 | $8.2706 | $30.23 | +590.60% |
| April, 2028 | $12.87 | $10.85 | $12.91 | +772.45% |
| May, 2028 | $16.23 | $13.53 | $16.25 | +1,001% |
| June, 2028 | $18.94 | $16.90 | $18.95 | +1,184% |
| July, 2028 | $21.95 | $19.60 | $22.05 | +1,388% |
| August, 2028 | $25.64 | $22.42 | $25.74 | +1,638% |
| September, 2028 | $28.39 | $26.13 | $28.39 | +1,824% |
| October, 2028 | $31.32 | $29.05 | $31.43 | +2,024% |
| November, 2028 | $35.18 | $31.96 | $35.21 | +2,285% |
| December, 2028 | $11.08 | $9.5857 | $35.93 | +650.97% |
Perspective Therapeutics Inc Stock (CATX) Price Forecast for 2029
The 2029 price forecast for Perspective Therapeutics Inc Stock (CATX) is $26.26 on average, with a high prediction of $41.62 and a low estimate of $10.90. This represents an +1,680% increase from the previous price of $1.475.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $14.97 | $11.83 | $15.01 | +914.92% |
| February, 2029 | $18.12 | $15.75 | $18.13 | +1,128% |
| March, 2029 | $21.25 | $18.89 | $21.28 | +1,341% |
| April, 2029 | $24.77 | $22.02 | $24.80 | +1,579% |
| May, 2029 | $28.93 | $25.48 | $28.93 | +1,861% |
| June, 2029 | $32.12 | $29.63 | $32.19 | +2,078% |
| July, 2029 | $35.64 | $32.89 | $35.73 | +2,316% |
| August, 2029 | $39.88 | $36.32 | $40.07 | +2,604% |
| September, 2029 | $11.62 | $10.90 | $41.62 | +688.10% |
| October, 2029 | $16.21 | $12.58 | $16.24 | +998.94% |
| November, 2029 | $19.74 | $17.07 | $19.82 | +1,238% |
| December, 2029 | $23.36 | $20.63 | $23.36 | +1,484% |
Perspective Therapeutics Inc Stock (CATX) Price Forecast for 2030
Perspective Therapeutics Inc Stock (CATX) is expected to reach an average price of $29.77 in 2030, with a high forecast of $47.32 and a low forecast of $12.22. This signifies an +1,918% surge from the last price of $1.475.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $28.22 | $24.25 | $28.25 | +1,813% |
| February, 2030 | $32.00 | $29.04 | $32.04 | +2,069% |
| March, 2030 | $35.74 | $32.82 | $35.74 | +2,323% |
| April, 2030 | $39.45 | $36.53 | $39.61 | +2,575% |
| May, 2030 | $44.37 | $40.24 | $44.42 | +2,908% |
| June, 2030 | $12.22 | $12.22 | $47.32 | +728.53% |
| July, 2030 | $17.16 | $13.05 | $17.24 | +1,063% |
| August, 2030 | $21.21 | $18.17 | $21.22 | +1,338% |
| September, 2030 | $25.23 | $22.17 | $25.24 | +1,611% |
| October, 2030 | $30.44 | $26.24 | $30.56 | +1,963% |
| November, 2030 | $34.70 | $31.43 | $34.76 | +2,253% |
| December, 2030 | $39.00 | $35.72 | $39.07 | +2,544% |
1.64%
0.09%
Cap:
|
Volume (24h):